M&S Decisions will participate in the QSPc conference

Quantitative Systems Pharmacology Conference 2026

In April, the M&S Decisions team will take part in the Quantitative Systems Pharmacology Conference 2026 (QSPс2026, https://www.qspc.eu/qspc2026/home), held on 8–10 April in the historic city center of Leiden, the Netherlands. QSPC is a major field defining meeting in quantitative systems pharmacology that brings together researchers from academia, industry, and regulatory agencies every four years.

QSPC2026 will focus on novel computational and experimental approaches in QSP, as well as mechanistic and physiology based PK/PD: from disease and target models to their integration into decision making in drug R&D. The program features plenary lectures from leading and early career scientists, poster sessions, satellite workshops, and extensive networking opportunities.

M&S Decisions will be represented with the poster “Integrated QSP platform for systemic lupus erythematosus: from mechanistic pathways to latent disease trajectory”, demonstrating how a unified QSP platform can be used to study SLE and support the development of new therapeutic strategies. The work focuses on linking detailed mechanistic descriptions of immune dysregulation with clinically observable disease activity and latent disease trajectories. For our team, this is a great opportunity to discuss QSP platforms for autoimmune diseases and beyond with the global QSP community.